Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NIH Conflict Of Interest Reg Attracts Criticism From Transparency Advocates

This article was originally published in The Gray Sheet

Executive Summary

A new upgrade to the National Institutes of Health’s1995 regulations overseeing researcher conflict of interests is intended as “an insurance plan” against potential trouble downstream, NIH Director Francis Collins says. But a key change in the final rule compared to an earlier proposal is attracting criticism from transparency advocates.

You may also be interested in...



NIH Conflict Of Interest Database Causing Fight At White House OMB

A government watchdog group is worried that the White House Office of Management and Budget is about to take the teeth out of the National Institute of Health's proposed new conflict of interest rule.

NIH Translational Center To Study Cell-Based Toxicity Tests, Offer Industry Grants

Toxicity testing is one area in which NIH Director Francis Collins expects the proposed National Center for Advancing Translational Science to help industry speed up drug development.

Proposed Rule For Physician Payment Reporting Expected By Summer

CMS's Office of Policy will issue a proposed rule as early as this summer explaining how companies should implement the physician payment reporting requirements authorized in the health reform law, an agency official said.

Related Content

Topics

UsernamePublicRestriction

Register

OM014142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel